Clinical Trial Update: Carboplatin and Etoposide in Combination With Vorinostat for Patients With Extensive Stage Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of carboplatin and etoposide with vorinostat in extensive-stage small cell lung cancer has been terminated; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)
• Vorinostat (vorinostat)

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Small Cell Lung Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2018-10-15